Skip to main content
S&P 5007,739.44+0.46%DOW51,740.96+0.76%NASDAQ27,084.26+0.54%BTC$83,937.00-0.52%ETH$2,692.34+0.39%GOLD$4,326.90+0.67%OIL$92.10-2.65%
Smart Investors Daily
XX

NYSE · XXII

22nd Century Group, Inc.

Consumer Defensive · Tobacco

$1.51

Down-$0.22 (-14.57%)

Updated Sep 25, 2026, 4:21 PM

SID Score

3.1/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
2.89M
P/E ratio
-0.6
Dividend yield
0.00%
52-week range
$0.46 – $27.00
Volume
855.26K
Avg. volume
1.63M

Price performance

XXII price history

1M range · 20 trading sessions · Daily adjusted prices

XXII closed at $1.51 after 20 trading sessions, down 50.33% for the selected period.

Last close
$1.51
Period change
-50.33%
Period low
$1.51
Period high
$3.20
Daily close
View OHLC price history
XXII OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Sep 24, 2026$1.86$1.86$1.1501$1.51855.26K
Sep 23, 2026$1.81$2.60$1.69$2.342.7M
Sep 22, 2026$1.77$1.8855$1.77$1.8127.08K
Sep 21, 2026$1.81$1.85$1.757$1.7720.79K
Sep 18, 2026$1.75$1.89$1.74$1.7931.97K
Sep 17, 2026$1.74$1.7898$1.6802$1.7713.77K
Sep 16, 2026$1.81$1.81$1.671$1.7214.81K
Sep 15, 2026$1.82$1.8399$1.74$1.79521.77K
Sep 14, 2026$1.98$1.98$1.80$1.8521.02K
Sep 11, 2026$2.01$2.06$1.9318$1.9911.17K
Sep 10, 2026$2.14$2.1674$1.99$2.04529.94K
Sep 9, 2026$2.27$2.31$2.10$2.1322.33K
Sep 8, 2026$2.41$2.43$2.25$2.2921.93K
Sep 4, 2026$2.29$2.4992$2.28$2.4530.77K
Sep 3, 2026$2.33$2.3995$2.27$2.2820.18K
Sep 2, 2026$2.61$2.61$2.30$2.3459.4K
Sep 1, 2026$3.18$3.80$2.51$2.61441.98K
Aug 31, 2026$3.35$3.35$3.08$3.2014.22K
Aug 28, 2026$3.09$3.18$3.069$3.1314.44K
Aug 27, 2026$3.31$3.3256$3.00$3.0434.05K

Latest XXII news

The latest Smart Investors Daily articles mentioning XXII.

Stock researchCompany · Overview

XXII research

Overview

Company profile and research snapshot.

Company profile

22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$82.50
Implied upside
—
Analysts
—
XXII recent ratings
DateFirmRatingTarget
Aug 23, 2023Roth MKMBuy—
Aug 17, 2023Alliance Global PartnersNeutral—
Aug 15, 2023Dawson JamesBuy—
Aug 15, 2023TD CowenMarket Perform—
Nov 9, 2022Alliance Global PartnersBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Sep 1, 2026

22nd Century CEO & Chairman Larry Firestone: Improved Gross Margin, ~5,000 Retail Outlets and >$50B Market Opportunity Highlight Mid-Year Stockholder Letter

VLN® Category Leader Accelerates 2H 2026 Growth Phase as Same-Store Sales Climb 22nd Century Accelerates 2H 2026 Commercial Execution MOCKSVILLE, N.C., Sept. 01, 2026 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), the leader in low-nicotine tobacco, low-nicotine cigarettes and the only tobacco products company focused on reducing the harms of smoking through nicotine reduction, today issued the following letter to stockholders from Lawrence Firestone, the Chief Executive Officer of

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By